In both invasive breast cancer and lung adenocarcinoma, DNA damage response pathways were enriched in the DNM1L mRNA high quartile, consistent with engagement of DNA damage (Figures S2D, S2E, and S2F; Table S1). This evidence concerns the gene DNM1L and lung adenocarcinoma.